The first case of the Zollinger-Ellison syndrome treated from the outset continuously for more than a year with the histamine H2-receptor antagonist cimetidine is reported.
Introduction
In 1955, Zollinger and Ellison described the syndrome of recurrent peptic ulceration, gastric hypersecretion and an associated pancreatic tumour arising from non-5 cells of the islets of the pancreas. Gastric hypersecretion in this condition is due to the production of large quantities of gastrin or a gastrinlike hormone by the tumour. Histamine is a mediator in the parietal cell response to gastrin, the site of action being characterized as the H2-receptor. Histamine H2-receptor antagonists reduce gastric acid secretion by blocking the action of histamine at H2-receptor sites. The newest agent in this group, cimetidine, has been shown markedly to inhibit basal and stimulated gastric secretion in normal subjects (Burland et al., 1975a; Pounder et al., 1976) and in patients with duodenal ulceration Barbezat and Bank, 1977 ). Cimetidine appears to cause no significant side effects and to be free from the potential risk of agranulocytosis associated with its predecessor, metiamide (Burland et al., 1975b) . Initial reports indicate that cimetidine promotes healing of duodenal ulcers (Blackwood et al., 1976; Bodemar and Walan, 1976; Gray et al., 1977 1975 complaining of dyspepsia, vomiting and diarrhoea which had occurred in increasingly severe episodes since he had undergone vagotomy and partial gastrectomy in 1971. The operation has been carried out because of persistent vomiting and radiological evidence of ulceration at the pyloro-duodenal region. At operation there was evidence of old ulceration of the first part of the duodenum and a tumour was found involving the pylorus and the first part of the duodenum along the anterior wall. It was thought that the tumour was a leiomyoma but histological appearances were considered to be those of a carcinoid tumour.
Endoscopy was undertaken soon after admission. The lower oesophagus was severely inflamed and multiple ulcers were present above the oesophagogastric junction. The gastric remnant was large with coarse nodular folds. The mucosa was uniformly inflamed and friable and a giant gastric ulcer involved much of the anterior wall of the stomach. There was also a deep penetrating ulcer of the posterior wall. The gastrectomy stoma was ulcerated throughout its circumference and there was ulceration of both efferent and afferent loops.
Basal gastric secretion studies showed a volume of 320 ml/hr and acid secretion of 28-8 mmol/hr. In response to insulin-stimulated hypoglycaemia the volume was 330 ml/hr and acid secretion 39 mmol/ hr. Plasma gastrin levels were reported as >120 pmol/l (normal range 0-1-23 pmol/l) and on dilution levels of 472 and 504 pmol/l were reported. An intravenous injection of secretin 2 units/kg resulted in a rise of plasma gastrin from 640 pmol/l to 920 pmol/l within 15 min.
In January 1976 the patient developed a melaena which required transfusion. Two weeks later, he suffered a partial thickness myocardial infarct. Invasive investigation, laparotomy and further gastric surgery have been considered but rejected because the risks of surgery are high, the patient is now 70 years old, is, as far as he is concerned, in good health, and has suffered amyocardial infarction.
Discussion
The history suggests a gastrin-producing tumour, possibly in the pancreas or more probably a secondary tumour in the liver. That the original tumour lay outside the pancreas is of interest but is recognized. In a series reported by Howe (1965) , 10%I of tumours occurred in the duodenal wall and 2%4 as discrete adenoma of the pyloric region of the stomach. Carcinoid tumours are microscopically similar to gastrinoma and distinction may be possible only by immunological preparations for gastrin (Stremple, 1975) .
The place of long term treatment with histamine H2-receptor antagonists in the management of cases of the Zollinger-Ellison syndrome will become clear as experience accumulates. In patients who are young or relatively young, provided the diagnosis has been made before any gastric surgery, total gastrectomy with tumour removal followed by monitoring of the serum gastrin levels would appear still to be the treatment of choice and a period of preoperative treatment with a histamine H2-receptor antagonist would improve the patient's condition and render the surgeon's task less difficult. However, surgical treatment is unlikely to be straight-forward as most patients will already have had some form of gastric surgery and Wilson and Ellison (1966) reported an associated survival of only 53%O in patients who underwent total gastrectomy subsequent to a lesser procedure. After 14 months' treatment there has been no indication to increase the dose of cimetidine. Treatment has been given continuously, repeated absorption curves have shown some variability but effective blood levels have been reported on each occasion. 
